| Literature DB >> 27170700 |
François De Guio1, Eric Jouvent2, Geert Jan Biessels3, Sandra E Black4, Carol Brayne5, Christopher Chen6, Charlotte Cordonnier7, Frank-Eric De Leeuw8, Martin Dichgans9, Fergus Doubal10, Marco Duering11, Carole Dufouil12, Emrah Duzel13, Franz Fazekas14, Vladimir Hachinski15, M Arfan Ikram16, Jennifer Linn17, Paul M Matthews18, Bernard Mazoyer19, Vincent Mok20, Bo Norrving21, John T O'Brien22, Leonardo Pantoni23, Stefan Ropele14, Perminder Sachdev24, Reinhold Schmidt14, Sudha Seshadri25, Eric E Smith26, Luciano A Sposato15, Blossom Stephan27, Richard H Swartz4, Christophe Tzourio12, Mark van Buchem28, Aad van der Lugt29, Robert van Oostenbrugge30, Meike W Vernooij29, Anand Viswanathan31, David Werring32, Frank Wollenweber11, Joanna M Wardlaw33, Hugues Chabriat34.
Abstract
Brain imaging is essential for the diagnosis and characterization of cerebral small vessel disease. Several magnetic resonance imaging markers have therefore emerged, providing new information on the diagnosis, progression, and mechanisms of small vessel disease. Yet, the reproducibility of these small vessel disease markers has received little attention despite being widely used in cross-sectional and longitudinal studies. This review focuses on the main small vessel disease-related markers on magnetic resonance imaging including: white matter hyperintensities, lacunes, dilated perivascular spaces, microbleeds, and brain volume. The aim is to summarize, for each marker, what is currently known about: (1) its reproducibility in studies with a scan-rescan procedure either in single or multicenter settings; (2) the acquisition-related sources of variability; and, (3) the techniques used to minimize this variability. Based on the results, we discuss technical and other challenges that need to be overcome in order for these markers to be reliably used as outcome measures in future clinical trials. We also highlight the key points that need to be considered when designing multicenter magnetic resonance imaging studies of small vessel disease.Entities:
Keywords: Magnetic resonance imaging; atrophy; brain volume; cerebral small vessel disease; lacunes; marker; microbleeds; perivascular spaces; repeatability; reproducibility; variability; white matter hyperintensities
Mesh:
Substances:
Year: 2016 PMID: 27170700 PMCID: PMC4976752 DOI: 10.1177/0271678X16647396
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.200